净收入 更改
Amarin USD -1.22M 6.51M 2025-12
Ardelyx USD -37.6M 37.2M 2026-03
Baxter International USD 126M 141M 2026-06
Bayer EUR 219M 2.54B 2026-06
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
Biogen USD 97.5M 222M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
Insmed USD -13.24M 150.32M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
J&J USD 5.53B 299M 2026-06
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Moderna USD -1.34B 517M 2026-03
Omeros USD -32.23M 23.81M 2024-09
Pfizer USD -248M 2.94B 2026-06
PTC Therapeutics USD -2.81M 132.16M 2026-03
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Teva Pharmaceutical Industries USD -576M 945M 2026-06
United Therapeutics USD 333M 58.1M 2026-06
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06